Analytic Investors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$31M Buy
789,927
+577,018
+271% +$23.5M 0.35% 78
2016
Q2
$8.71M Buy
212,909
+173,169
+436% +$6.91M 0.1% 156
2016
Q1
$1.63M Buy
+39,740
New +$1.47M 0.02% 333
2015
Q2
Sell
-70,074
Closed -$3.02M 602
2015
Q1
$3.02M Sell
70,074
-120,991
-63% -$5.24M 0.04% 212
2014
Q4
$8.59M Sell
191,065
-895,850
-82% -$36.5M 0.12% 144
2014
Q3
$41.6M Buy
1,086,915
+730,940
+205% +$29.6M 0.6% 48
2014
Q2
$14.4M Buy
+355,975
New +$14.6M 0.23% 108
2014
Q1
Sell
-763,663
Closed -$29.2M 589
2013
Q4
$29.2M Sell
763,663
-112,786
-13% -$3.88M 0.48% 61
2013
Q3
$29.1M Buy
876,449
+30,665
+4% +$995K 0.47% 67
2013
Q2
$26M Buy
+845,784
New +$28.1M 0.43% 75

Other funds holding ORCL

Analytic Investors's ORCL Position: Q3 2016 in Review

Analytic Investors increased its Oracle (ORCL) stake by 271% in Q3 2016, buying an estimated $23.5M and bringing the position to 789,927 shares worth $31M. The position accounts for 0.35% of the portfolio, ranked #78.

Analytic Investors first reported a position in ORCL in Q2 2013 and has held it in 10 quarters since. The position peaked at $41.6M in Q3 2014. 1,485 funds tracked by Wall St. Rank hold ORCL as of Q3 2016.

  • Analytic Investors held 789,927 shares of Oracle worth $31M as of Q3 2016.
  • Analytic Investors bought 577,018 Oracle shares in Q3 2016, an estimated $23.5M.
  • Oracle made up 0.35% of Analytic Investors's portfolio in Q3 2016, its #78 holding.
  • Analytic Investors first reported a position in Oracle in Q2 2013 and has held it in 10 quarters since.
  • Analytic Investors's Oracle position peaked at $41.6M in Q3 2014.
  • 1,485 funds tracked by Wall St. Rank held Oracle as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.